Russian pharmaceutical companies are eyeing expanding in the United Arab Emirates (UAE) by launching production of their drugs and establishing their manufacturing facilities in the local market, according to recent statements, by Russia’s Ministry of Industry and Trade Denis Manturov, The Pharma Letter’s local correspondent reports.
According to him, as part of the plans is producing of bioengineered drugs. In addition, particular attention will be given to the area of nosology and monoclonal antibodies as well as some other areas where Russia has the necessary competencies.
Currently the Russian government, together with some of the country’s leading drugmakers, is finishing forming the list of Russian pharmaceutical companies, which may establish their production facilities within the territory of the UAE. That list will be also a subject to approval of the UAE’s Ministry of Economy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze